Summary
The role of insulin-like growth factor I (IGF-I) in the growth and development of bladder cancer cells was investigated using cultured human cell lines representing differentiated (RT-4, 5637) or undifferentiated (T-24, J-82, TCC-SUP) transitional cell carcinoma (TCC). In the presence of 2% serum, IGF-I significantly stimulated the growth of all cell lines. The proliferation of T-24, 5637, and RT-4 cells was more sensitive to IGF-I than that of J-82 and TCC-SUP cells. [125I]IGF-I binding to 5637 and J-82 cells was significantly higher than that to T-24 and TCC-SUP cells (P<0.001). RT-4 cells possessed the lowest binding capacity among the cell lines tested. Scatchard analysis of [125I]IGF-I binding to four of the five cell lines indicated a single binding site for IGF-I, with apparent dissociation constants (K d) of 1.27, 1.18, 1.34, and 1.39 nmol/l for TCC-SUP, J-82, 5637, and T-24, respectively. Therefore, the difference observed in [125I]IGF-I binding among the bladder cancer cell lines was attributed to the difference of IGF-I binding sites and not to a change in receptor binding affinity. Cross-linking studies supported the suggestion that [125I]IGF-I was bound to a receptor on these cells. The results indicate that cultured human bladder cancer cells contain functional IGF-I receptors. A differentiated cell line, RT-4, possesses significantly fewer IGF-I receptors than other cell lines. This suggests that the overexpression of IGF-I receptor may reflect the malignant potential of bladder cancer cells.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Berger MS, Greenfield C, Gullick WJ, Haley J, Downward J, Neal DE et al (1987) Evaluation of epidermal growth factor receptors in bladder tumors. Br J Cancer 56:533–537
Bleday R, Tzanakakis GN, Schwalke MA, Wanebo HJ, Vezeridis MP (1990) Epidermal growth factor stimulation and metastatic rate in human pancreatic carcinoma cell lines. J Surg Res 49:276–279
Eloch A (1984) Induced cell differentiation in cancer therapy. Cancer Treat Rep 68:199–205
Bunenik J, Baresova M, Viklicky V, Jakoubkova J, Sainerova H, Donner J (1973) Established cell line of urinary bladder carcinoma (T24) containing tumor-specific antigen. Int J Cancer 11:765–773
Czech MP (1989) Signal transmission by the insulin-like growth factors. Cell 59:235–238
Daughaday WH (1990) Editorial: the possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 127:1–4
D'Ercole AJ, Stiles AD, Underwood LE (1984) Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanism of action. Proc Natl Acad Sci USA 81:935–939
Dulak NC, Temin HM (1973) A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication-stimulating activity for embryo fibroblasts. J Cell Physiol 81:153–160
Fiorelli G, De Bellis A, Longo A, Giannini S, Natali A, Constantini A et al. (1991) Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J Clin Endocrinol Metab 72:740–746
Froesch ER, Schmid C, Schwander J, Zapf J (1985) Action of insulin-like growth factors. Annu Rev Physiol 47:443–467
Goustin AS, Leof EB, Shipley GD, Moses HL (1986) Growth factors and cancer. Cancer Res 46:1015–1029
Heldin C-H, Westermark B (1984) Growth factors: mechanism of action and relation to oncogeneses. Cell 37:9–20
Kurose H, Yamaoka K, Okada S, Nakajima S, Seino Y (1990) 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3]increases insulin-like growth factor I (IGF-I) receptors in clonal osteoblastic cells: study on interaction of IGF-I and 1,25-(OH)2D3. Endocrinology 126:2088–2094
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277:680–685
Laiho M, Keski-Oja J (1989) Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res 49:2533–2553
Lee K, Smith P, Weiss GH, Cockett ATK (1990) Clonal growth of bladder cancer cells in a double layer soft agar assay: needless addition of multiple culture supplements. Urol Res 18:197–200
Liotta LA (1986) Tumor invasion and metastasis: role of the extracellular matrix. Rhoads memorial award lecture. Cancer Res 46:1–7
Lund PK, Moats-Staats BM, Hynes MA, Simmons JG, Jansen M, D'Ercole AJ, Van Wyk JJ (1986) Somatomedin C/insulin-like growth factor I and insulin-like growth factor II mRNAs in rat fetal and adult tissues. J Biol Chem 261:14539–14544
Messing EM, Reznikoff CA (1987) Normal and malignant human epithelium: in vitro effects of epidermal growth factor. Cancer Res 47:2230–2235
Monaghan P, Ormerod MG, O'Hare MJ (1990) Epidermal growth factor receptors and EGF-responsiveness of the human breast-carcinoma cell line PMC42. Int J Cancer 46:935–943
Murphy AJ, Bell GI, Friesen HG (1987) Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. Endocrinology 12:1279–1282
Nayak SK, O'Toole C, Price ZH (1977) A cell line from an anaplastic transitional cell carcinoma of human urinary bladder. Br J Cancer 35:142–151
Neal DE, Marsh C, Bennet MK, Abel PD, Hall RR, Sainsbury JRC et al (1985) Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet I:366–368
Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL (1990) The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65:1619–1625
O'Toole C, Price ZH, Ohnuki Y, Unsgaard B (1978) Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma. Br J Cancer 38:64–76
Pilch PF, Czech MP (1980) The subunit structure of the high-affinity insulin receptor. J Biol Chem 255:1722–1731
Pollak MN, Polychronakos C, Yousefi S, Richard M (1988) Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cells. Biochem Biophys Res Commun 154:326–331
Reiss K, Ferber A, Travali S, Procu P, Phillips PD, Baserga R (1991) The protooncogene c-myb increases the expression of insulin-like growth factor I and insulin-like growth factor I receptor messenger RNAs by a transcriptional mechanism. Cancer Res 51:5997–6000
Rigby CC, Franks LM (1970) A human tissue culture cell line from a transitional cell tumor of the urinary bladder: growth, chromosome pattern and ultrastructure. Br J Cancer 24:746–754
Ritvos O, Rutanen E, Pekonen F, Jalkanen J, Suikkari A, Ranta T (1988) Characterization of functional type I insulin-like growth factor receptors from human choriocarcinoma cells. Endocrinology 122:395–401
Scatchard G 81949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672
Sporn MB, Roberts AB (1985) Autocrine growth factors and cancer. Nature 313:745–747
Stracke ML, Engel JD, Wilson LW, Rochler MM, Liotta LA, Schiffmann E (1989) The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J Biol chem 264:21544–21549
Talavera F, Reynolds RK, Roberts JA, Menon KM (1990) Insulin-like growth factor I receptors in normal and neoplastic human endometrium. Cancer Res 50:3019–3024
Weiss RE, Liu BC-S, Ahlering T, Dubean L, Droller MJ (1990) Mechanisms of human bladder tumor invasion: role of protease cathepsin. B. J Urol 144:798–804
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iwamura, M., Ishibe, M., Sluss, P.M. et al. Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines. Urol. Res. 21, 27–32 (1993). https://doi.org/10.1007/BF00295188
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00295188